A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

NCT05110976 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: AZD8630
DRUG: Placebo

Sponsor

AstraZeneca